Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

This publication has 21 references indexed in Scilit:

• Durable HBeAg and HBsAg seroconversions after lamivudine for chronic hepatitis B (CHB)
  Journal of Hepatology, 2000
• Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
  Hepatology, 2000
• Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States
  New England Journal of Medicine, 1999
• Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
  Hepatology, 1999
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• Dynamics of hepatitis B virus infection in vivo
  Journal of Hepatology, 1997
• Viral dynamics in hepatitis B virus infection.
  Proceedings of the National Academy of Sciences, 1996
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
  Proceedings of the National Academy of Sciences, 1991
• Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: Clinical significance and correlation with serological and biochemical markers
  Hepatology, 1991